Sam Altman, chief executive officer of OpenAI Inc., at Station F during the AI Action Summit in Paris, France, on Tuesday, Feb. 11, 2025. France is set to announce a total of €109 billion in investment in artificial intelligence projects in the country by companies, funds and other sources over the coming years, President Emmanuel Macron said on the eve of a two-day AI Action Summit. Photographer: Nathan Laine/Bloomberg | Image Credits:Nathan Laine/Bloomberg / Getty Images
Loading the player…
AI companies are clustering around healthcare and fast.
In just the past week, OpenAI bought health startup Torch, Anthropic launched Claude for healthcare, and Sam Altman-backed MergeLabs closed a $250 million seed round at an $850 million valuation. The money and products are pouring into health and voice AI, but so are concerns about hallucination risks, inaccurate medical information, and massive security vulnerabilities in systems handling sensitive patient data.
Watch as Equity podcast hosts Kirsten Korosec, Anthony Ha, and Sean O’Kane dig into why the AI world is suddenly obsessed with health care, what other products can expect an AI-makeover, and more.
Subscribe to Equity on YouTube, Apple Podcasts, Overcast, Spotify and all the casts. You also can follow Equity on X and Threads, at @EquityPod.